Boeing (NYSE:BA) has resumed 737 MAX deliveries to China, marking a potential thaw in U.S.-China trade tensions. A new 737 MAX aircraft, painted in Xiamen Airlines livery, landed on Monday at Boeing’s Zhoushan completion center near Shanghai after departing Seattle and refueling in Hawaii and Guam.
The U.S. planemaker had paused deliveries to China in April as both countries escalated tariffs. However, with a 90-day rollback of some trade restrictions announced in late May, Boeing confirmed it would restart deliveries in June.
Flight tracking data from Flightradar24 revealed the same aircraft had initially been delivered to Zhoushan in March but was returned to the U.S. in mid-April amid halted orders from Chinese carriers. Monday’s landing signals renewed activity after Boeing repatriated at least three jets from China in April that were meant for final delivery stages.
Boeing, Xiamen Airlines, and the Civil Aviation Authority of China (CAAC) have not commented on the resumed delivery. Despite recent trade uncertainty, China remains a key market for Boeing, accounting for roughly 10% of its commercial aircraft backlog.
With representatives from China and the U.S. set to meet in London to discuss trade policy, the return of Boeing jets may reflect cautious optimism for improved relations. In April, Boeing reported plans to deliver 50 aircraft to Chinese airlines this year, with 41 already in production or pre-built.
Although Boeing had considered reselling grounded aircraft to other markets, the planes remained in inventory, signaling the company’s anticipation of resumed business with China. The latest delivery could be a step toward stabilizing Boeing’s relationship with one of its most vital international markets.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



